VEGF对大鼠肝部分移植术后肝功能及肝脏再生的影响
|
摘要
肝脏移植是各类终末期肝病唯一有效的治疗方法,供肝需求的急剧增加和来源的缺乏严重限制肝移植的发展。近年来活体部分肝移植开展迅速,但临床上仍存在许多问题尚待解决,如移植肝的活性、移植肝大小与受体的匹配、移植术后肝功能不全等。其中移植术后肝功能不全是决定术后治疗效果的一个最重要的因素,除与免疫排斥、营养等因素外,还与肝脏缺血再灌注损伤,肝脏再生能力损害有密切关系。
肝脏再生而是由成熟的肝细胞在各种不同的肝损伤刺激下发生基因表达和激素分泌的改变,导致处于G0期的肝细胞重新进入G1期而开始细胞增殖,当肝脏被修复后,这种增殖循环便停止。肝再生是一个复杂的过程,涉及肝细胞和非实质细胞及其分泌的细胞因子,是它们共同作用的结果。肝细胞生长因子(HGF)首先被证实为培养的肝细胞的血源性丝裂原,HGF及其受体是肝细胞增殖的基本因子,被认为是肝再生始动因子,是促使肝细胞由G1期向S期转化的最主要因素。HGF主要是由非实质肝细胞(LSEC,贮脂细胞及Kupffer细胞等)分泌,通过旁分泌、自分泌等途径刺激肝再生。IL-6在部分肝切除术后由肝脏(主要为非实质性细胞)及肠道内产生,并且被证实是肝再生必不可少的介质。
部分肝移植术后肝再生更是一个特殊、复杂的细胞增殖过程。一方面由于肝脏体积锐减导致肝细胞大量丢失,启动肝再生过程。另一方面肝脏低温保存-缺血再灌注,导致肝脏内皮细胞的损伤,特别是肝窦内皮细胞(LSEC)。LSEC损伤后细胞水肿或血小板和白细胞粘附到损伤的内皮细胞表面导致肝脏微循环障碍,继而发生肝实质细胞的损伤。LSEC的损伤不仅是导致移植后肝脏功能不全的一个重要因素,而且是影响肝部分移植术后肝再生活性的一个主要原因。因为肝窦内皮细胞是肝脏再生的“感应期器”,在肝脏部分切除术后被激活,通过旁分泌作用分泌HGF、IL-6、TNF-a、NO等细胞因子启动和促经肝脏再生。因此,在肝脏移植术后及时发现内皮细胞的损伤并找到有效的治疗策略并及时处理,对改善肝移植术后肝功能不全和增强肝脏再生活性有非常重要的意义。
VEGF是一种具有多种潜能的细胞因子,主要是促进血管内皮的增生,体外实验表明能促进肝窦内皮细胞的增生、抑制其凋亡。在肝部分切除术后能促进肝脏增生。最近研究显示,VEGF能减轻由化学因素诱导的急性肝脏损害,并降低其死亡率。有学者研究报道大鼠肝部分切除术后,给予高压氧治疗,能明显降低术后肝脏损害,并发现一个重要的因素为VEGF分泌增加及肝窦内皮细胞增生。那么VEGF能否改善肝脏部分移植术后肝窦内皮细胞功能?能否降低肝脏缺血再灌注损伤?能否改善术后肝功能,目前该方面的研究很少。
PI3K/Akt信号途径在细胞增殖、细胞周期及生存中起到重要作用。Akt酶是PI3K下游直接靶蛋白,由PI3K激活后才发挥其生物学效应。Akt作为细胞生存通路P13 K/Akt的关键分子,在促进细胞生长、增殖,促进细胞运动、侵袭,抑制细胞凋亡、促进血管生成等方面发挥了重要作用。活性的Akt表达能刺激无血清环境中的肝星状细胞的增殖,显性负性的Akt蛋白表达能抑制血小板源性生长因子(PDGF)诱发的肝星状细胞的增殖。Akt能够调节NOS的活性、进而增加N0的合成,抑制低血流量下的血小板聚集并与超氧化物结合,形成无毒代谢产物NO3-;从而使肝细胞避免氧自由基所致损害,保护肝细胞。那么VEGF作为一种人体体内最强的血管生长因,能否活化肝窦内皮细胞内Akt酶,发挥其生物学效应呢?目前未见该方面研究报道。
本研究通过建立大鼠减体积肝脏移植模型,观察VEGF对大鼠肝部分移植术后肝功能、肝窦内皮细胞形态及功能、术后肝细胞增殖的影响,探讨VEGF能否改善大鼠肝部分移植术后肝功能、促进肝再生。并通过观察VEGF对术后血清HGF、IL-6浓度、肝窦内皮细胞HGF mRNA表达及Akt酶活化的影响,进一步探讨VEGF改善大鼠部分肝移植术后肝功能、降低缺血再灌注损伤,增强肝再生活性的机制,旨在为临床减体积肝脏移植术后肝功能不全提供新的治疗策略。
本实验取得的主要成果如下:
1.建立了稳定的大鼠系列减体积肝移植模型,同时确定了大鼠30%肝移植术可作为肝部分移植术后急性肝损伤动物模型。为肝部分移植后急性肝损伤、肝再生的研究提供了实验基础。
2.明确了外源性VEGF能明显减轻肝窦内皮细胞的损害,减少炎性细胞的浸润,降低血清HA的浓度,改善大鼠肝脏移植术后肝窦内皮细胞功能,从而降低肝脏缺血再灌注损伤。
3.外源性VEGF能显著降低肝部分移植术后血清ALT、AST、TBIL的浓度,改善术后肝功能,提高术后生存率。
4.外源性VEGF能促进术后肝细胞PCNA的表达,增强肝脏再生活性,促进肝再生。
5. VEGF能增强大鼠肝部分移植术后肝窦内皮细胞活化的Akt激酶的表达,并且促进HGF、IL-6等细胞因子的分泌,提出VEGF可能通过活化肝窦内皮细胞Akt酶,激活术后肝窦内皮细胞分泌HGF、IL-6等细胞因子,从而启动和促进肝脏再生新的观点。
Liver transplantation has become the ultimate effective therapia for end stage liver dieases. The deficient supply of donator liver, however, has become the major agent to restric the development of livertransplantation. To meet this problem, the living donor tecthnic, with transplantation of liver segments, have been carried out promptly. But many problems, such as the activity of recipient graft, the matching to recieper and liver function failure after operation, are to be solved. The liver function failure of graft has been a most important agent that decide therapeutic efficacy of liver transplantation, and witch concerned with liver ischemical reperfusion injury and the suffering activity of liver regeneration besides immunization rejection and nutritic agents.
Liver regeneration has been attributed to hepatocyte proliferation following different kind of injury, reflecting the priming of G0 cells and shift to G0 to the G1/S, accompanied by changes of gene expression and hormone secretion. Once the renovation completed, the proliferation circulation quit. The procedure of liver is very complic, which include the heaptocytes and nonparenchymal cell and its secretion of a large numberof cytokines. First of all , the growth factors, produced by nonparenchymal cell (LSEC,and Ito's cell Kupffer cell), is proved to be the mitogen which promtes hepatocyte shift from G1 to S. Il-6 is proved to be a indispensable mediator produced majorly by nonparenchymal cell in liver and intestinal gland。The liver regeneration procedure after partial liver transplantation is more complicate and specialer, on the one hand ,the liver regeneration was prompted by the loss of liver tissue ,on the other hand the liver sindusoial endothelial cells were injuried by liver ischemical reperfusion injury, accompanied with liver microcirculation disturbance and hepatic parenchymal cells injury because of cellularedema and platelet leucocyte adhesion. And the injury of LSEC has been a major agent which effect the activity of liver regeneration, because the LSEC is the“inducer”of liver regeneration, HGF/IL-6 and TNF-a、NO secreated by LSEC after liver Partial excision can priminted and enhance hepatocytes proliferation. It is very important to improve liver function and enhance the activity of liver regeneration after liver transplantation that to find the injury of LSEC and givie effective therapy .
Vascular endothelial growth factor(VEGF), a potent angiogenic factor, can improve blood vessel endothelium cells hyperplasy, and it has been proved that can promote sinus hepaticus hyperplasy and suppress its apoptosis vitro. VEGF can enhance liver regeneration after partial hepatectomy. Recently study indicated that VEGF can relieve acute severe liver injury(ALI) induced by chemical factor, VEGF treatment significantly reduced the mortality rate of ALI in the rat, and it may provide a new therapeutic strategy for ALI. It was reported that hyperbaric oxygen treatment significantly reduced the liver function damage,and enhance the proliferation of hepatocytes and LSECs ,meanwhile the hyperbaric oxygen treatment significantly increased the expression of VEGF protein in the regenerating liver .Can VEGF improve LSEC function or decrease liver ischemical reperfusion injury? Up to now there are few reports .
The role of the phosphoinositide 3-kinase/Akt-signal pathway is very important on differentiation, migration, proliferation and anti-apoptosis, invasion, Angiogenesis. Akt is the downstream target protein of PI3K,and bring into it’s full biological effect after activated by PI3K.Activated Akt stimulates liver stella cells proliferation under no serum condition. Blockage of the expression of Akt can suppress liver stella cells proliferation evoked by platelet-derived growth factor. Akt can accommodate the activity of nitric oxide synthase, and increase the synthesis of nitric oxide, and inhibit platelet aggregation and its combining with hyperoxide, and prevent hepatocytes from damage caused by oxygen free radical. Can VEGF activate Akt of LSEC? Up to now there are few reports.
This study identified that VEGF can improve hepatic function and promote liver regeneration by observation the effects of VEGF on the functional biochemistry, the level of hyaluronic acid , the morphous of LSECs, and the expression index of proliferating cell nuclear antigen of hepatocytes of rat following partial liver transplantation. To explore the mechanism of effects of VEGF on improving Liver function, degrading ischemical reperfusion injury, and enhancing the activity of heaptocytes proliferation, we observed the effects of VEGF on the levels of HGF, Il-6, and the expression of HGF mRNA and Akt of LSEC after rat partial liver transplantation. This may provide a new therapy strategy for hepatic inadequacy after for-small-size partial liver transplantation for clinical.
In this project we explore the role of VEGF in partial liver transplantation, the results are followed:
1. A stabile animal model of rats serial reduced-size liver transplantation were set up and the effect of ratio of rat liver graft on liver function and survival rate were evaluated. This provides a experiment foundation for exploring liver regeneration after partial liver transplantation
2. To identify that exogenous VEGF can improve the LSEC function,low down liver ischemical reperfusion injury, and elevate the survival rate of rats subjected partial liver transplantation. This may provide a new clinical treatment strategy for hepatic inadequacy after reduced-size liver transplantation.
3. Our experiment show that VEGF can enhance the secretion of HGF, IL-6 by activated LSEC through Akt phosphorylated pathway and promote liver regeneration after partial liver transplantation.
肝脏再生而是由成熟的肝细胞在各种不同的肝损伤刺激下发生基因表达和激素分泌的改变,导致处于G0期的肝细胞重新进入G1期而开始细胞增殖,当肝脏被修复后,这种增殖循环便停止。肝再生是一个复杂的过程,涉及肝细胞和非实质细胞及其分泌的细胞因子,是它们共同作用的结果。肝细胞生长因子(HGF)首先被证实为培养的肝细胞的血源性丝裂原,HGF及其受体是肝细胞增殖的基本因子,被认为是肝再生始动因子,是促使肝细胞由G1期向S期转化的最主要因素。HGF主要是由非实质肝细胞(LSEC,贮脂细胞及Kupffer细胞等)分泌,通过旁分泌、自分泌等途径刺激肝再生。IL-6在部分肝切除术后由肝脏(主要为非实质性细胞)及肠道内产生,并且被证实是肝再生必不可少的介质。
部分肝移植术后肝再生更是一个特殊、复杂的细胞增殖过程。一方面由于肝脏体积锐减导致肝细胞大量丢失,启动肝再生过程。另一方面肝脏低温保存-缺血再灌注,导致肝脏内皮细胞的损伤,特别是肝窦内皮细胞(LSEC)。LSEC损伤后细胞水肿或血小板和白细胞粘附到损伤的内皮细胞表面导致肝脏微循环障碍,继而发生肝实质细胞的损伤。LSEC的损伤不仅是导致移植后肝脏功能不全的一个重要因素,而且是影响肝部分移植术后肝再生活性的一个主要原因。因为肝窦内皮细胞是肝脏再生的“感应期器”,在肝脏部分切除术后被激活,通过旁分泌作用分泌HGF、IL-6、TNF-a、NO等细胞因子启动和促经肝脏再生。因此,在肝脏移植术后及时发现内皮细胞的损伤并找到有效的治疗策略并及时处理,对改善肝移植术后肝功能不全和增强肝脏再生活性有非常重要的意义。
VEGF是一种具有多种潜能的细胞因子,主要是促进血管内皮的增生,体外实验表明能促进肝窦内皮细胞的增生、抑制其凋亡。在肝部分切除术后能促进肝脏增生。最近研究显示,VEGF能减轻由化学因素诱导的急性肝脏损害,并降低其死亡率。有学者研究报道大鼠肝部分切除术后,给予高压氧治疗,能明显降低术后肝脏损害,并发现一个重要的因素为VEGF分泌增加及肝窦内皮细胞增生。那么VEGF能否改善肝脏部分移植术后肝窦内皮细胞功能?能否降低肝脏缺血再灌注损伤?能否改善术后肝功能,目前该方面的研究很少。
PI3K/Akt信号途径在细胞增殖、细胞周期及生存中起到重要作用。Akt酶是PI3K下游直接靶蛋白,由PI3K激活后才发挥其生物学效应。Akt作为细胞生存通路P13 K/Akt的关键分子,在促进细胞生长、增殖,促进细胞运动、侵袭,抑制细胞凋亡、促进血管生成等方面发挥了重要作用。活性的Akt表达能刺激无血清环境中的肝星状细胞的增殖,显性负性的Akt蛋白表达能抑制血小板源性生长因子(PDGF)诱发的肝星状细胞的增殖。Akt能够调节NOS的活性、进而增加N0的合成,抑制低血流量下的血小板聚集并与超氧化物结合,形成无毒代谢产物NO3-;从而使肝细胞避免氧自由基所致损害,保护肝细胞。那么VEGF作为一种人体体内最强的血管生长因,能否活化肝窦内皮细胞内Akt酶,发挥其生物学效应呢?目前未见该方面研究报道。
本研究通过建立大鼠减体积肝脏移植模型,观察VEGF对大鼠肝部分移植术后肝功能、肝窦内皮细胞形态及功能、术后肝细胞增殖的影响,探讨VEGF能否改善大鼠肝部分移植术后肝功能、促进肝再生。并通过观察VEGF对术后血清HGF、IL-6浓度、肝窦内皮细胞HGF mRNA表达及Akt酶活化的影响,进一步探讨VEGF改善大鼠部分肝移植术后肝功能、降低缺血再灌注损伤,增强肝再生活性的机制,旨在为临床减体积肝脏移植术后肝功能不全提供新的治疗策略。
本实验取得的主要成果如下:
1.建立了稳定的大鼠系列减体积肝移植模型,同时确定了大鼠30%肝移植术可作为肝部分移植术后急性肝损伤动物模型。为肝部分移植后急性肝损伤、肝再生的研究提供了实验基础。
2.明确了外源性VEGF能明显减轻肝窦内皮细胞的损害,减少炎性细胞的浸润,降低血清HA的浓度,改善大鼠肝脏移植术后肝窦内皮细胞功能,从而降低肝脏缺血再灌注损伤。
3.外源性VEGF能显著降低肝部分移植术后血清ALT、AST、TBIL的浓度,改善术后肝功能,提高术后生存率。
4.外源性VEGF能促进术后肝细胞PCNA的表达,增强肝脏再生活性,促进肝再生。
5. VEGF能增强大鼠肝部分移植术后肝窦内皮细胞活化的Akt激酶的表达,并且促进HGF、IL-6等细胞因子的分泌,提出VEGF可能通过活化肝窦内皮细胞Akt酶,激活术后肝窦内皮细胞分泌HGF、IL-6等细胞因子,从而启动和促进肝脏再生新的观点。
Liver transplantation has become the ultimate effective therapia for end stage liver dieases. The deficient supply of donator liver, however, has become the major agent to restric the development of livertransplantation. To meet this problem, the living donor tecthnic, with transplantation of liver segments, have been carried out promptly. But many problems, such as the activity of recipient graft, the matching to recieper and liver function failure after operation, are to be solved. The liver function failure of graft has been a most important agent that decide therapeutic efficacy of liver transplantation, and witch concerned with liver ischemical reperfusion injury and the suffering activity of liver regeneration besides immunization rejection and nutritic agents.
Liver regeneration has been attributed to hepatocyte proliferation following different kind of injury, reflecting the priming of G0 cells and shift to G0 to the G1/S, accompanied by changes of gene expression and hormone secretion. Once the renovation completed, the proliferation circulation quit. The procedure of liver is very complic, which include the heaptocytes and nonparenchymal cell and its secretion of a large numberof cytokines. First of all , the growth factors, produced by nonparenchymal cell (LSEC,and Ito's cell Kupffer cell), is proved to be the mitogen which promtes hepatocyte shift from G1 to S. Il-6 is proved to be a indispensable mediator produced majorly by nonparenchymal cell in liver and intestinal gland。The liver regeneration procedure after partial liver transplantation is more complicate and specialer, on the one hand ,the liver regeneration was prompted by the loss of liver tissue ,on the other hand the liver sindusoial endothelial cells were injuried by liver ischemical reperfusion injury, accompanied with liver microcirculation disturbance and hepatic parenchymal cells injury because of cellularedema and platelet leucocyte adhesion. And the injury of LSEC has been a major agent which effect the activity of liver regeneration, because the LSEC is the“inducer”of liver regeneration, HGF/IL-6 and TNF-a、NO secreated by LSEC after liver Partial excision can priminted and enhance hepatocytes proliferation. It is very important to improve liver function and enhance the activity of liver regeneration after liver transplantation that to find the injury of LSEC and givie effective therapy .
Vascular endothelial growth factor(VEGF), a potent angiogenic factor, can improve blood vessel endothelium cells hyperplasy, and it has been proved that can promote sinus hepaticus hyperplasy and suppress its apoptosis vitro. VEGF can enhance liver regeneration after partial hepatectomy. Recently study indicated that VEGF can relieve acute severe liver injury(ALI) induced by chemical factor, VEGF treatment significantly reduced the mortality rate of ALI in the rat, and it may provide a new therapeutic strategy for ALI. It was reported that hyperbaric oxygen treatment significantly reduced the liver function damage,and enhance the proliferation of hepatocytes and LSECs ,meanwhile the hyperbaric oxygen treatment significantly increased the expression of VEGF protein in the regenerating liver .Can VEGF improve LSEC function or decrease liver ischemical reperfusion injury? Up to now there are few reports .
The role of the phosphoinositide 3-kinase/Akt-signal pathway is very important on differentiation, migration, proliferation and anti-apoptosis, invasion, Angiogenesis. Akt is the downstream target protein of PI3K,and bring into it’s full biological effect after activated by PI3K.Activated Akt stimulates liver stella cells proliferation under no serum condition. Blockage of the expression of Akt can suppress liver stella cells proliferation evoked by platelet-derived growth factor. Akt can accommodate the activity of nitric oxide synthase, and increase the synthesis of nitric oxide, and inhibit platelet aggregation and its combining with hyperoxide, and prevent hepatocytes from damage caused by oxygen free radical. Can VEGF activate Akt of LSEC? Up to now there are few reports.
This study identified that VEGF can improve hepatic function and promote liver regeneration by observation the effects of VEGF on the functional biochemistry, the level of hyaluronic acid , the morphous of LSECs, and the expression index of proliferating cell nuclear antigen of hepatocytes of rat following partial liver transplantation. To explore the mechanism of effects of VEGF on improving Liver function, degrading ischemical reperfusion injury, and enhancing the activity of heaptocytes proliferation, we observed the effects of VEGF on the levels of HGF, Il-6, and the expression of HGF mRNA and Akt of LSEC after rat partial liver transplantation. This may provide a new therapy strategy for hepatic inadequacy after for-small-size partial liver transplantation for clinical.
In this project we explore the role of VEGF in partial liver transplantation, the results are followed:
1. A stabile animal model of rats serial reduced-size liver transplantation were set up and the effect of ratio of rat liver graft on liver function and survival rate were evaluated. This provides a experiment foundation for exploring liver regeneration after partial liver transplantation
2. To identify that exogenous VEGF can improve the LSEC function,low down liver ischemical reperfusion injury, and elevate the survival rate of rats subjected partial liver transplantation. This may provide a new clinical treatment strategy for hepatic inadequacy after reduced-size liver transplantation.
3. Our experiment show that VEGF can enhance the secretion of HGF, IL-6 by activated LSEC through Akt phosphorylated pathway and promote liver regeneration after partial liver transplantation.
引文
1. Michalopolous GK.Hepatocyte growth factor in liver growth and differentiation.J boil Chem 1995;In:Strain AJ,Diehl AM,editors ,Liver Growth andRepair.London:Chapman﹠Hall:1998:P 219-239
2. Suzuki A,Iwama A,Miyashita H,Nakauchi H,Taniguchi H.Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells.Development 2003;130:2513-2524
3. Daveau M,Scotte M,Francois A,Coulouarn C,Ros G,Tallet Y,Hiron M,Hellot MF,Salier JP.Hepatocyte growth factor,transforming growth factor alpha,and their receptors as combined markers of prognosis in hepatocellular carcinoma.Mol Carcinog 2003; 36:130-141
4. Miki C, Iriyama K, Gunson BK, et al. Influence of intraoper-ative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function. Arch Surg 1997;132(2):136-141.
5. Mogensen KE, Lewerenz M, Reboul J, et al. The type I interferon receptor: structure, function, and evolution of a family business. J Interferon Cytokine Res 1999; 19(10): 1069–98.
6. Sakamoto T, Liu Z, Murase N, et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology1999;29(2): 403–11.
7. Miki C, Iriyama K, Gunson BK, et al. Influence of intraoperative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function. Arch Surg 1997; 132(2): 136–141.
8. Kim YI, Hwang YJ, Song KE, et al. Hepatocyte protection by a protease inhibitor against ichemia/reperfusion injury of human liver. J Am Coll Surg 2002; 195(1): 41–50.
9. Kovalovich K, DeAngelis RA, Li W, et al. Increased toxin induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000; 31(1): 149–59.
10. Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274(5291): 1379-83.
11. Zimmers TA, McKillop IH, Pierce RH, et al. Massive liver growth in mice induced bysystemic interleukin-6 administration. Hepatology 2003; 38(6): 326–334
12. Chen Ping, Dong Xiaoling, Zhu Jin, et al. Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats[J]. Arch Med Res. 2006 ,37(5):576-83.
13.孙凯刘志苏孙权.肝窦内皮细胞在肝脏缺血再灌注损伤中的作用[J]。国外医学(消化系疾病分册),2003, 04(23);:209-210
14. Shimizu H, Mitsuhashi N, Ohtsuka M,et al. Vascular endothelial growth factor and angiopoietins regulate sinusoidal regeneration and remodeling after partial hepatectomy in rats.[J] World J Gastroenterol, 2005, 11(46):7254.
15. ichi H, Taketomi A, Yoshizumi T, et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy.J Hepatol. 2006 Jul;45(1):28-34. Epub 2006 Feb 3.
16. Donahower B, McCullough SS, Kurten R, et al Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity. Am J Physiol Gastrointest Liver Physiol. 2006 Jul; 291(1):G102-9. Epub 2006 Mar 24.
17. Marino G, Piazzese E, Gruttadauria S, et al. New model of liver regeneration induced through use of vascular endothelial growth factor.Transplant Proc. 2006 May;38(4):1193-4.
18. Bockhorn M, Goralski M, Prokofiev D, et al. VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res. 2007 Apr;138(2):291-9. Epub 2007 Feb 1.
19. Reif S, Lang A, Lindquist JN , et al. The role of focal adhesion kinase phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type I collagen expression[J ] .Biol Chem,200 3 ,278(10):8 083-8090.
20. Vander Heiden M G,Plas D R,Rathmell J C,et al.Growth factors can influence cell growth and survival through effects on glucose metabolism [J] , Mol Cell Biol,2001,21(17);5 899-5912.
21. Dimmocler S, Flcuing J, Fisslthaler B, et al. Activation of nitric oxide syntheis in endothelial cell by Akt-dependent phospharylation[ J].Nature,1999,399:601-605.
22. Haberal M, Emiro?lu R, Karakayali H ,et al. Living - donor transplants : part of answer to organ shortage. Transplant Proc. 2001;33(5):2619-2620.
23. Kamada N, Calne RY. Orthotopic liver transplantation in the rat:technique using cuff for portal vein anastomosis and biliary drainage. Transplantation ,1979 ;28 :47～49.
24. Keefe EB. Liver transplantation: current status and novel approaches to liver replacement [J ] ,Gastroenterology ,2001 ,120 :749– 762
25. Bilzer M, Gerbes AL. Preservation injury of the liver mechanisms and novel therapeutic strategies[J ] ,Hepatol ,2000 ,32 :508 - 515
26. Foss A , Zoucas E , Steinbauer F , et al . Liver regeneration following 68 % partial orthotopic liver transplantation in therat [J ], Eur Surg Res ,1993 ,25(3) : 174– 180
27.张浩,王学浩,张峰.灌注压力对肝移植物活性的影响.中国普外基础学临床杂志,1996 ; 6 (3) : 140～142.
28. Xia R, Emond JC. Orthotopic partial liver transplantation in the rat :A model of 70 %hepatectomy and reduced size liver transplantation.Transplantation, 1993;56: 1041~1043
29. Kawasaki S, Makuuchi M, Matsunami H,et al . Living related liver transplantation in adults[J]. Ann Surg. 1998 Feb;227(2):269-274.
30.孙凯,刘志苏,孙权。肝窦内皮细胞在肝脏缺血再灌注损伤中的作用[J]。国外医学(消化系疾病分册), 2003;23(4):209-212.
31. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover[J]. Intern Med. 1997, 242(1):27-33.
32.吕随峰,王孟龙,付志仁等。血清透明质酸在大鼠肝脏低温保存-灌注损伤中的作用[J].第二军医大学学报,2001;22(1):77-79.
33. Namisaki T, Yoshiji H, Kojima H, et al .Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats.[J] Hepatol.,2006, 44(3):568-76.
34. Marino G, Piazzese E, Gruttadauria S.et al. New model of liver regeneration induced through use of vascular endothelial growth factor[J]. Transplant Proc,2006 ; 38(4):1193-1194.
35. Ijichi H, Taketomi A, Yoshizumi T, et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy.[J ] Hepatol, 2006,45(1):28-36.
36. Donahower B, McCullough SS, Kurten R, et al.Vascular endothelial growth factor andhepatocyte regeneration in acetaminophen toxicity. Am J Physiol Gastrointest[J] Liver Physiol. 2006 ,291(1):102-109
37.朱瑾,陈平,董晓灵,等.大鼠肝窦内皮细胞的分离、培养及鉴定[J]。中华肝脏病杂志,2004;(12)10:633-644.
38. Chen Ping, Dong Xiaoling, Zhu Jin, et al. Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats[J]. Arch Med Res. 2006 ,37(5):576-83.
39. Chijiiwa K, Nakano K, Kameoka N, et al. Proliferation cell nuclear antigent, Plasma fibronectin and liver regeration rat after seventy percent hepaectomy in normal and cirrhotic rats[J]. Surgery 1994; 116(3): 544-52.
40. Ping C, Lin Z, Jiming D, Jin Z. et al. The phosphoinositide 3-kinase/Akt-signal pathway mediates proliferation and secretory function of hepatic sinusoidal endothelial cells in rats after partial hepatectomy[J].Biochem Biophys Res Commun.2006, 14;342(3):887-93
41. Koniaris LG, McKillop IH, Schwartz SI, et al. Liver regeneration[J]. J Am Coll Surg. 2003 ,197(4):634-59.
42. Fausto N ,Riehle KJ .Mechanisms of liver regeneration and their clinical implications[J ] .Hepatobiliary Pancreat Surg ,2005 ,12 (3) :1812189.
43. Malik R ,Selden C ,Hodgson H. The role of non-parenchymal cells in liver growth[J ] . Semin Cell Dev Biol ,2002 ,13 (6) :425-431.
44. Kohli V, Selzner M, Madden JF, et al: Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation. 1999; 67:1099-1105.
1. Young CS, Palma JM, Mosher BD, et al. Hepatic ischemia/reperfusion injury in P-selectin and intercellular adhesion molecule-1 double-mutant mice[J]. Am Surg,2001; 67(8):737-744.
2. Wu RQ,Xu YX,Song XH. Adhesion molecule and proinflammatory cytokine gene expression in hepatic sinusoidal endothelial cells following cecal ligation and puncture[J].World J Gastroenterol. 2001;7(1):128-130.
3. Kojima N, Sato M, Suzuki A, Sato T, Satoh S, Kato T, Senoo H. Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver[J]. Hepatology. 2001;34(4 Pt 1):751-757.
4. Neubauer K, Wilfling T, Ritzel A,et al. G. Platelet-endothelial cell adhesion molecule-1 gene expression in liver sinusoidal endothelial cells during liver injury and repair[J]. Hepatol. 2000;32(6):921-932.
5. Aiba M, Takeyoshi I, Ohwada S, et al. Novel nitric oxide donor (FK409) amelioratesliver damage during extended liver resection with warm ischemia in dogs[J].Am Coll Surg. 2001;193(3):264-271.
6. Geller DA, Chia SH, Takahashi Y, et al.Protective role of the L-arginine-nitric oxide synthase pathway on preservation injury after rat liver transplantation[J]. Parenter Enteral Nutr. 2001;25(3):142-7.
7. UhlmannG ,U hlmannS ,S piegelHU et al.Administration of a selective endothelin-a receptor antagonist (BSF 208075) improves hepatic warm ischemia/reperfusion injury in pigs [J] Invest Surg,2001;14.(1) 31 -45.
8. Ricciardi R, Schaffer BK, Shah SA, et al. Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury[J].2001;5(3):322-329.
9. Serracino-Inglott F, Habib NA.et al. Hepatic ischemia-reperfusion injury[J].Am J Surg,2001;181(2):160-166.
10. Peralta C, Rull R, Rimola A, et al. Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat[J]. Transplantation. 2001;71(4):529-536.
11. Malik R, Selden C, Hodgson H. The role of non-parenchymal cells in liver growth[J].Semin Cell Dev Biol,2002;13(6):425-431.
12. Teoh N,Field J,Sutton J,et al. Dual role of tumor necrosis factor2alpha in hepatic ischemia2reperfusion injury :studies in tumor necrosis factor2 alpha gene knockout mice[J ] . Hepatology ,2004;39 (2) :412-421.
13. Teoh N ,Leclercq I , Pena AD , et al. Low-dose TNF-alpha protects against hepatic ischemia reperfusion injury in mice:implications for preconditioning[J]. Hepatology, 2003 ,37 (1):118-128.
14. Webber EM,Bruix J , Pierce RH , et al. Tumor necrosis factor primes hepatocytes for DNA replication in the rat [J ].Hepatology ,1998 ;28(5):1226-1234.
15. Yamada Y,Webber EM,Kirillova I,et al. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor :require2 ment for type 1 but not type 2 receptor [J] Hepatology ,1998 ;28 (4) :959-970.
16. Fausto N ,Riehle KJ.Mechanisms of liver regeneration and their clinical implications[J]. Hepatobiliary Pancreat Surg ,2005 ;12 (3) :181-189.
17. StreetzKL ,Luedde T, Manns MP, et al. Interleukin 6 and liver regeneration[J].Gut,2000; 47 (2) :309-312.
18. Iimuro Y,Nishiura T, Hellerbrand C, et al.NF-kappa B prevents apoptosis and liver dysfunction during liver regeneration[J ] . J Clin Invest ,1998 ;101 (4) :802-811.
19. Iimuro Y,Nishiura T ,Hellerbrand C , et al . NF-kappa B prevents apoptosis and liver dysfunction during liver regeneration[J ] . J Clin Invest ,1998 ;101 (4) :802-811.
20. Chen C , Edelstein LC , Gelinas C. The RelP NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl2x (L) [J ] . Mol Cell Biol ,2000 ;20 (8) :2687-2695.
21. Liu H ,Lo CR , Czaja MJ.NF-κB inhibition sensitizes hepatocytes to TNFa induced apoptosis through a sustained activation of JNK and c-Jun[J]. Hepatology, 2002; 35(4) :772-778.
22. Li W,Liang X,Kellendonk C , et al. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration [ J] . J Biol Chem,2002 ;277(32) :28411-28417.
23. Sakuda S ,Tamura S ,Yamada A , et al . Activation of signal transducer and activator transcription 3 and expression of suppressor of cytokine signal 1 during liver regeneration in rats[J ]. Hepatol ,2002 ;36 (3) : 378-384.
24. Koniaris LG,McKillop IH ,Schwartz SI , et al . Liver regeneration[J].Am Coll Surg , 2003;,197(4) :634-659.
25. Fausto N ,Riehle KJ .Mechanisms of liver regeneration and their clinical implications[J]. Hepatobiliary Pancreat Surg ,2005 ;12 (3) :181-189.
26. Chen Ping, Dong Xiaoling, Zhu Jin, et al. Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats[J]. Arch Med Res. 2006 ;37(5):576-83.
27. Ping C, Lin Z, Jiming D, Jin Z, et al.The phosphoinositide 3-kinase/Akt-signal pathway mediates proliferation and secretory function of hepatic sinusoidal endothelial cells in rats after partial hepatectomy[J]Biochem Biophys Res Commun. 2006 ;342(3):887-893.
28. Klein D, Demory A, Peyre F, et al . Wnt2 acts as a cell type-specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway [J]Hepatology. 2008;47(3):1018-1031.
29. Matsumoto K, Honda K, Kobayashi N. Protective effect of heat preconditioning of ratliver graft resulting in improved transplant survival[J].Transplantation. 2001;71(7): 862-868.
30. Arai M, Thurman RG, Lemasters JJ. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of nonparenchymal cells and the phenomenon of heterologous preconditioning Liver Transpl[J]. 2001;7(4):292-299.
31. Rentsch M, Post S, Palma P, et al.Anti-ICAM-1 blockade reduces postsinusoidal WBC adherence following cold ischemia and reperfusion, but does not improve early graft function in rat liver transplantation [J].Hepatol. 2000 ;32(5):821-8.
32. Ghobrial R, Amersi F, Stecker K,et al. Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides[J]. Transplant Proc. 2001;33(1-2):538-543.
33. Namisaki T, Yoshiji H, Kojima H, et al. Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats [J]. Hepatol. 2006;44(3):568-575.
34. Namisaki T, Yoshiji H, Kuriyama S, et al. A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats[J]. Hepatol Res. 2006;35(3):199-203.
1. Paavonen K, Horelli-Kuitunen N, Chilov D,et al. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively[J].Circulation. 1996;93(6):1079-1082.
2. Joukov V, Pajusola K, Kaipainen A,et al. A novel vascular endothelial growth factor,VEGF-C,is a ligand for the Flt4(VEGFR-3)and KDR(VEGFR-2)receptor tyrosine kinases[J]. EMBO J,1996;15(7):1751-1759.
3. Marc G,KuKK E. Vascular endothelial growth factor D(VEGF-D)is a ligand for the tyrosine kinases VEGF receptor 2(Flk1)and VEGF receptor 3(Flt40)[J]. PNAS,1998;95:548 -553.
4. Maglione D, Guerriero V, Viglietto G,et al. Isolation of a Human Placenta cDNA Coding for a Protein Related to the Vascular Permeability Factor[J]. Proc Natl Acad Sci U S A. 1991;88(20):9267-71.
5. Wise LM, Veikkola T, Mercer AA,. Vascular endothelial growth factor(VEGF)-like protein from virus NZ2 binds to VEGFR2 and neuropilin-1[J].Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3071-6 .
6. JohannesW, Lena CW, Agneta S, et al. Different signal transduc2tion p roperties of KDR and Flt - 1, two recep tors for vascular endo2thelial growth factor. J Biol Chem, 1994, 269 ( 43) : 26 988 -26 995.
7. Koch AE, Harlow LA, Haines GK, et al.Vascular endothelial growth factor- A cytokine modulating endothelial function in rheumatoid arthritis [J]. Immunol,1994; 152(8):4149-4156.
8. Meyer RD, Rahimi N. Comparative structure-function analysis of VEGFR-1 andVEGFR-2: What have we learned from chimeric systems[J], 2003;995:200-207.
9. Zhao J, Hu J, Cai J, et al. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma[J]. Chin Med J ( Engl) , 2003;116 (5) : 772 - 776.
10.陶厚权王瑞年.血管内皮生长因子与肿瘤[J].肿瘤,1997,17(1):52—54.
11. Marti HH, RisauW. Systemic hypoxia changes the organ– specific distribution of vascular endothelial growth factor and its receptors[J]. Proc Natl Acad Sci U S A. 1998;95(26):15809-15814.
12. Takahashi Y, Bucana CD, Cleary KR, et al.. p53, vessel count, and vascular endothelial growth factor expression in human colon cancer[J].Int J Cancer,1998;79(1):34-38.
13. VonMarschall Z, Scholz A, Cramer T, et al. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis[J]. J Natl Cancer Inst, 2003;95 (6) : 437 -448.
14. Malecki M, Trembacz H, Szaniawska B,et al.Vascular endothelial growth factor and soluble FLT-1 receptor interactions and biological implications[J].Oncol Rep. 2005;14(6):1565-1569.
15. Marchand GS, Noiseux N, Tanguay JF,et al. Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors[J]. Am J Physiol Heart Circ Physiol. 2002;282(1):194-204.
16. Masood R, Cai J, Zheng T,et al.Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A. 1997;94(3):979-84.
17. Rieder G, Hatz RA, Moran AP, et al. Role of adherence in interleukin - 8 induction in Helicobacter pylori - associated gastritis[J]. Infect Immun, 1997;65 (9) : 3622 -3630.
18. AsanoM, Yukita A, Suouki H. Wide spectrum of antitumor activity of a neutralizingmonoclonal antibody to human vascular endothclial growth factor[ J ]. Jpn J Cancer Res, 1999;90 (1) : 93-100.
19. Hc Y, Smith SK, Day KA, et al. Alternative sp licing of vascular endothelial growth factor (VEGF) - R1 ( FLT-1) pre–mRNA is important for the regulation ofVEGF activity[J]. Mol Endocrinol,1999, 13 (4) : 537 - 545.
20. Perez-Ruiz M ,Ros J,Morales-Ruiz M,et al.Vascular endothelial growth factorproduction in pe ritoneal macorophages of cirrhotic pa tients regulation by cytokines and bacterial lipopoly sacharide [J] .Hepatolog) ,1999;29(4):1057-l063.
21. Rosmorduo 0,Wendum D,Corpechot C,et a1.Hpatecellular Hypoxia induced vascular endothelial growth factor expression and an glogenesis in experimental biliary cirrhosis[J].Am J Pathol,1999;155(4):1065-1073.
22. Kraft A,Weindel K,Ochs A, et a1.Vascular endothelial growth factor in the sera and effusions of patients with malignant and non-malignant disease. [J].Cancer,1999; 85(1);178-187.
23. Desider G,Ferri C.Circulating vascular endothelial growth factor levels are dec- reased in patients with chronic hepatitis and liver cirrhosis depending on the degree of hepatic demge[J].Clin Sci(colch);2000;99(2):159-160.
24. Assy N, PaiziM, GaitiniD, et al. Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension[J]. World J Gastroenterol, 1999;5 (4) : 296 - 300.
25. Akiyoshi F, SaraM, Suzuki H, et al. Serum vascular endothelial growth factor levels in various liver diseases[J]. Dig Dis Sci, 1998;43 (1) : 41 - 45.
26. El-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver[J].Hepatology.1998;27(6):1554-62.
27. Raleigh JA, Calkins - Adams DP, Rinker LH, et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinoma using p imonidazole as a hypoxia marker[J].Cancer Res,1998;58 (17) :3765 -3768.
28. Yoshiji H, Kuriyama S, Yoshii, et al. Vascular endothelial growth factor and recep tor interaction is a p rerequisite formurine hepatic fibrogenesis[J]. Gut, 2003;52(9) :1347 - 1354.
29. Niimi Y,Mochida S, MatsuiA, et al. PKC– and MAPK - independent upregulation of VEGF receptor expressions in human umbilical venous endothelial cells following VEGF stimulation[J]. HepaZol Res, 2001;21(3):261-267.
30. Hiscock N,Fischer C P,Pilegaard H,et al. Vascular endothelial growth factor mRNA expression and arteriovenous balance in response to prolonged,submaximal exercise inhumans[J]. Am J Physiol Heart Circ Physiol,2003;285;1759-1763.
31. Hiroaki Shimizu,Masaru Miyazaki. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats[J]. Journal of Hepatology,2001;34:683 - 689.
32. Mochida S, Ishikawa K, Inao M, et a1. Increased exp ressions of vascular endothe lial growth factor and its recop tors, f1 t -1 and KDR / flk - 1, in regenerating rat liver[J]. Biochem B iophys Res Commun, 1996;226 (1) : 176-179.
33. Kraizer Y,Mawasi N, Seagal J, et a1. Vascular endothelial growth factor and angiop oietin in liver regeneration[J]. Biochem Biophys Res Commun, 200 l;287 (1):209 - 215.
34. Assy N, Spira G, Paizi M, et a1. Effect of Vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats[J]. Hepato1, 1999;30 (5) : 911- 9 l5.
35. Taniguchi E, Sakisaka S,Matsuo K, et a1. Expression and role of vascu1ar endothelial growth factor in liver regeneration after partia1 hepatectomy in rats[J]. J Histochem Cytochem,2001,49 (1 ):121 - l30.
36. Ronco MT, Francés D, de Luján Alvarez M,et al. Vascular endothelial growth factor and nitric oxide in rat liver regeneration[J]. Life Sci. 2007;81(9):750-755.
37. Bockhorn M, Goralski M, Prokofiev D,et al. VEGF is important for early liver regeneration after partial hepatectomy[J] Surg Res. 2007 Apr;138(2):291-299.
38. Sato T, El - Assal ON,Ono T, et a1. Sinusoida1 endothe1 ial ce1l pro1iferation and exp ression of angiopoietin /Tie fami1y in regenerating rat liver[J]. Hepatol, 2001; 34 (5): 690 - 698.
39. SengerD R, Galli SJ,Dvorak AM, et a1. Tumor cel1s secrete vascular permeability factor that promotes accumu1ation of ascites fluid[J]. Science, 1983, 219 (4587) : 983 - 985.
40. Akiyoshi F, Sara M, Suzuki H, et al.Serum vascular endothelial growth factor levels in various liver disease[J].Dig Dis Sei,1998;43(1):41.
41. Janczewska-Kazek E, Marek B, Pisula A,et al.Serum levels of vascular endothelial growth factor in chronic hepatitis C patients treated with interferon alpha and ribavirin[J]. Wiad Lek. 2007;60(3-4):120-123.
42. Marino G, Piazzese E, Gruttadauria S, et al. New model of liver regeneration induced through use of vascular endothelial growth factor[J].Transplant Proc,2006;38(4): 1193-1194.
43. Marino G, Piazzese E, Gruttadauria S,et al. Innovative use of the vascular endothelial growth factor in an experimental model of acute liver failure[J]. ,2004;25(3):61-64.
44. Donahower B, McCullough SS, Kurten R,et al. Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity[J].Am J Physiol Gastrointest Liver Physiol, 2006 ;291(1):G102-109.
45. Namisaki T, Yoshiji H, Kojima H,et al. Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats[J].J Hepatol. 2006 ;44(3):568-75.
46. Kusumanto YH, van Weel V, Mulder NH,et al. A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats[J]. Hepatol Res, 2006;35(3):199-203.
47. Ajioka I,Nishio R, Ikekita M, et a1. Establishment of heterotropic liver tissue mass with direct link to the host liver following implantation of hepatocytes transfected with vascular endothelial growth factor gene in mice[J]. Tissue Eng, 2001, 7 (3) : 335 - 344.
48. Yang ZF, Poon RT, Luo Y, et al. Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway[J]. J Immunol. 2004 ,15;173(4):2507-2515.
1. Fausto N, Webber EM. Control of liver growth[J]. Crit Rev Eukaryot Gene Expr 1993;3:117–135.
2. Fausto N. Liver regeneration[J]. J Hepatol 2000;32(Suppl 1):19–31.
3. Higgins GM, Anderson RM. Restoration of liver following partial surgical removal[J]. Arch Pathol 1931;12:186–202.
4. Giuliano R, Ramadori G, Armbrust T. Cytokines in the liver[J]. Eur J Gastroenterol Hepatol 2001;13:777–784.
5. Koniaris LG, McKillop IH, Schwartz SI, Zimmers TA. Liver regeneration[J].J Am Coll Surg 2003;197:634–659.
6. Daveau M, Scotte M, Francois A, et al.Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma[J].Mol Carcinogen 2003;36:130–141.
7. Suzuki A, Iwama A, Miyashita H, Nakauchi H, Taniguchi H. Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells[J]. Development 2003;130:2513–2524.
8. Peters M, Blinn G, Jostock T, et al. Buschenfelde KH, et al. Combined interleukin 6 and soluble interleukin-6 receptor accelerates murine liver regeneration[J]. Gastroenterology 2000;119:1663–1671.
9. Debonera F, Aldeguer X, Shen X, et al. Activation of interleukin-6/STAT3 and liver regeneration following transplantation[J]. J Surg Res 2001;96:289–295.
10. Tanaka H, Hashizume K, Enosawa S, Suzuki S. Successful transplantation of a 20% partial liver graft in rats: a technical innovation. J Surg Res 2003; 110: 409.
11. Guo L, Haga S, Enosawa S, et al. Improved Hepatic regeneration with reduced post-ischemic injury by redoxfactor-1 gene transfer in a rat small size-liver transplant model[J]. Am J Transplant 2004; 4: 879-887.
12. Chen Ping, Dong Xiaoling, Zhu Jin, et al. Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats[J]. Arch Med Res. 2006 ;37(5):576-583
13. Namisaki T, Yoshiji H, Kojima H, et al .Salvage effect of the vascular endothelialgrowth factor on chemically induced acute severe liver injury in rats[J]. Hepatol.,2006, 44(3):568-576.
14. Donahower B, McCullough SS, Kurten R, et al Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity[J]. Am J Physiol Gastrointest Liver Physiol. 2006 ; 291(1):G102-9.
15. Marino G, Piazzese E, Gruttadauria S, et al. New model of liver regeneration induced through use of vascular endothelial growth factor[J].Transplant Proc. 2006 ;38(4):1193-1194.
16. Namisaki T, Yoshiji H, Kojima H, et al .Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats[J]. Hepatol,2006, 44(3):568-576.
17. Marino G, Piazzese E, Gruttadauria S.et al. New model of liver regeneration induced through use of vascular endothelial growth factor[J]. Transplant Proc,2006 ; 38(4): 1193-1194.
18. Ijichi H, Taketomi A, Yoshizumi T, et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy.[J ] Hepatol, 2006,45(1):28-36.
19. Donahower B, McCullough SS, Kurten R, et al.Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity. Am J Physiol Gastrointest[J] Liver Physiol. 2006 ,291(1):102-109
20. Marino G, Piazzese E, Gruttadauria S.et al. New model of liver regeneration induced through use of vascular endothelial growth factor[J]. Transplant Proc,2006 ; 38(4):1193-1194.
21. Chen Ping, Dong Xiaoling, Zhu Jin, et al. Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats[J]. Arch Med Res. 2006 ,37(5):576-583.
22. Malik R, Selden C, Hodgson H. The role of non-parenchymal cells in liver growth[J]. Semin Cell Dev Biol 2002;13:425–431.
23. Higgins GM, Anderson RM. Restoration of liver following partial surgical removal[J]. Arch Pathol 1931;12:186–202.
2. Suzuki A,Iwama A,Miyashita H,Nakauchi H,Taniguchi H.Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells.Development 2003;130:2513-2524
3. Daveau M,Scotte M,Francois A,Coulouarn C,Ros G,Tallet Y,Hiron M,Hellot MF,Salier JP.Hepatocyte growth factor,transforming growth factor alpha,and their receptors as combined markers of prognosis in hepatocellular carcinoma.Mol Carcinog 2003; 36:130-141
4. Miki C, Iriyama K, Gunson BK, et al. Influence of intraoper-ative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function. Arch Surg 1997;132(2):136-141.
5. Mogensen KE, Lewerenz M, Reboul J, et al. The type I interferon receptor: structure, function, and evolution of a family business. J Interferon Cytokine Res 1999; 19(10): 1069–98.
6. Sakamoto T, Liu Z, Murase N, et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology1999;29(2): 403–11.
7. Miki C, Iriyama K, Gunson BK, et al. Influence of intraoperative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function. Arch Surg 1997; 132(2): 136–141.
8. Kim YI, Hwang YJ, Song KE, et al. Hepatocyte protection by a protease inhibitor against ichemia/reperfusion injury of human liver. J Am Coll Surg 2002; 195(1): 41–50.
9. Kovalovich K, DeAngelis RA, Li W, et al. Increased toxin induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000; 31(1): 149–59.
10. Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274(5291): 1379-83.
11. Zimmers TA, McKillop IH, Pierce RH, et al. Massive liver growth in mice induced bysystemic interleukin-6 administration. Hepatology 2003; 38(6): 326–334
12. Chen Ping, Dong Xiaoling, Zhu Jin, et al. Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats[J]. Arch Med Res. 2006 ,37(5):576-83.
13.孙凯刘志苏孙权.肝窦内皮细胞在肝脏缺血再灌注损伤中的作用[J]。国外医学(消化系疾病分册),2003, 04(23);:209-210
14. Shimizu H, Mitsuhashi N, Ohtsuka M,et al. Vascular endothelial growth factor and angiopoietins regulate sinusoidal regeneration and remodeling after partial hepatectomy in rats.[J] World J Gastroenterol, 2005, 11(46):7254.
15. ichi H, Taketomi A, Yoshizumi T, et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy.J Hepatol. 2006 Jul;45(1):28-34. Epub 2006 Feb 3.
16. Donahower B, McCullough SS, Kurten R, et al Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity. Am J Physiol Gastrointest Liver Physiol. 2006 Jul; 291(1):G102-9. Epub 2006 Mar 24.
17. Marino G, Piazzese E, Gruttadauria S, et al. New model of liver regeneration induced through use of vascular endothelial growth factor.Transplant Proc. 2006 May;38(4):1193-4.
18. Bockhorn M, Goralski M, Prokofiev D, et al. VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res. 2007 Apr;138(2):291-9. Epub 2007 Feb 1.
19. Reif S, Lang A, Lindquist JN , et al. The role of focal adhesion kinase phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type I collagen expression[J ] .Biol Chem,200 3 ,278(10):8 083-8090.
20. Vander Heiden M G,Plas D R,Rathmell J C,et al.Growth factors can influence cell growth and survival through effects on glucose metabolism [J] , Mol Cell Biol,2001,21(17);5 899-5912.
21. Dimmocler S, Flcuing J, Fisslthaler B, et al. Activation of nitric oxide syntheis in endothelial cell by Akt-dependent phospharylation[ J].Nature,1999,399:601-605.
22. Haberal M, Emiro?lu R, Karakayali H ,et al. Living - donor transplants : part of answer to organ shortage. Transplant Proc. 2001;33(5):2619-2620.
23. Kamada N, Calne RY. Orthotopic liver transplantation in the rat:technique using cuff for portal vein anastomosis and biliary drainage. Transplantation ,1979 ;28 :47～49.
24. Keefe EB. Liver transplantation: current status and novel approaches to liver replacement [J ] ,Gastroenterology ,2001 ,120 :749– 762
25. Bilzer M, Gerbes AL. Preservation injury of the liver mechanisms and novel therapeutic strategies[J ] ,Hepatol ,2000 ,32 :508 - 515
26. Foss A , Zoucas E , Steinbauer F , et al . Liver regeneration following 68 % partial orthotopic liver transplantation in therat [J ], Eur Surg Res ,1993 ,25(3) : 174– 180
27.张浩,王学浩,张峰.灌注压力对肝移植物活性的影响.中国普外基础学临床杂志,1996 ; 6 (3) : 140～142.
28. Xia R, Emond JC. Orthotopic partial liver transplantation in the rat :A model of 70 %hepatectomy and reduced size liver transplantation.Transplantation, 1993;56: 1041~1043
29. Kawasaki S, Makuuchi M, Matsunami H,et al . Living related liver transplantation in adults[J]. Ann Surg. 1998 Feb;227(2):269-274.
30.孙凯,刘志苏,孙权。肝窦内皮细胞在肝脏缺血再灌注损伤中的作用[J]。国外医学(消化系疾病分册), 2003;23(4):209-212.
31. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover[J]. Intern Med. 1997, 242(1):27-33.
32.吕随峰,王孟龙,付志仁等。血清透明质酸在大鼠肝脏低温保存-灌注损伤中的作用[J].第二军医大学学报,2001;22(1):77-79.
33. Namisaki T, Yoshiji H, Kojima H, et al .Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats.[J] Hepatol.,2006, 44(3):568-76.
34. Marino G, Piazzese E, Gruttadauria S.et al. New model of liver regeneration induced through use of vascular endothelial growth factor[J]. Transplant Proc,2006 ; 38(4):1193-1194.
35. Ijichi H, Taketomi A, Yoshizumi T, et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy.[J ] Hepatol, 2006,45(1):28-36.
36. Donahower B, McCullough SS, Kurten R, et al.Vascular endothelial growth factor andhepatocyte regeneration in acetaminophen toxicity. Am J Physiol Gastrointest[J] Liver Physiol. 2006 ,291(1):102-109
37.朱瑾,陈平,董晓灵,等.大鼠肝窦内皮细胞的分离、培养及鉴定[J]。中华肝脏病杂志,2004;(12)10:633-644.
38. Chen Ping, Dong Xiaoling, Zhu Jin, et al. Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats[J]. Arch Med Res. 2006 ,37(5):576-83.
39. Chijiiwa K, Nakano K, Kameoka N, et al. Proliferation cell nuclear antigent, Plasma fibronectin and liver regeration rat after seventy percent hepaectomy in normal and cirrhotic rats[J]. Surgery 1994; 116(3): 544-52.
40. Ping C, Lin Z, Jiming D, Jin Z. et al. The phosphoinositide 3-kinase/Akt-signal pathway mediates proliferation and secretory function of hepatic sinusoidal endothelial cells in rats after partial hepatectomy[J].Biochem Biophys Res Commun.2006, 14;342(3):887-93
41. Koniaris LG, McKillop IH, Schwartz SI, et al. Liver regeneration[J]. J Am Coll Surg. 2003 ,197(4):634-59.
42. Fausto N ,Riehle KJ .Mechanisms of liver regeneration and their clinical implications[J ] .Hepatobiliary Pancreat Surg ,2005 ,12 (3) :1812189.
43. Malik R ,Selden C ,Hodgson H. The role of non-parenchymal cells in liver growth[J ] . Semin Cell Dev Biol ,2002 ,13 (6) :425-431.
44. Kohli V, Selzner M, Madden JF, et al: Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation. 1999; 67:1099-1105.
1. Young CS, Palma JM, Mosher BD, et al. Hepatic ischemia/reperfusion injury in P-selectin and intercellular adhesion molecule-1 double-mutant mice[J]. Am Surg,2001; 67(8):737-744.
2. Wu RQ,Xu YX,Song XH. Adhesion molecule and proinflammatory cytokine gene expression in hepatic sinusoidal endothelial cells following cecal ligation and puncture[J].World J Gastroenterol. 2001;7(1):128-130.
3. Kojima N, Sato M, Suzuki A, Sato T, Satoh S, Kato T, Senoo H. Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver[J]. Hepatology. 2001;34(4 Pt 1):751-757.
4. Neubauer K, Wilfling T, Ritzel A,et al. G. Platelet-endothelial cell adhesion molecule-1 gene expression in liver sinusoidal endothelial cells during liver injury and repair[J]. Hepatol. 2000;32(6):921-932.
5. Aiba M, Takeyoshi I, Ohwada S, et al. Novel nitric oxide donor (FK409) amelioratesliver damage during extended liver resection with warm ischemia in dogs[J].Am Coll Surg. 2001;193(3):264-271.
6. Geller DA, Chia SH, Takahashi Y, et al.Protective role of the L-arginine-nitric oxide synthase pathway on preservation injury after rat liver transplantation[J]. Parenter Enteral Nutr. 2001;25(3):142-7.
7. UhlmannG ,U hlmannS ,S piegelHU et al.Administration of a selective endothelin-a receptor antagonist (BSF 208075) improves hepatic warm ischemia/reperfusion injury in pigs [J] Invest Surg,2001;14.(1) 31 -45.
8. Ricciardi R, Schaffer BK, Shah SA, et al. Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury[J].2001;5(3):322-329.
9. Serracino-Inglott F, Habib NA.et al. Hepatic ischemia-reperfusion injury[J].Am J Surg,2001;181(2):160-166.
10. Peralta C, Rull R, Rimola A, et al. Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat[J]. Transplantation. 2001;71(4):529-536.
11. Malik R, Selden C, Hodgson H. The role of non-parenchymal cells in liver growth[J].Semin Cell Dev Biol,2002;13(6):425-431.
12. Teoh N,Field J,Sutton J,et al. Dual role of tumor necrosis factor2alpha in hepatic ischemia2reperfusion injury :studies in tumor necrosis factor2 alpha gene knockout mice[J ] . Hepatology ,2004;39 (2) :412-421.
13. Teoh N ,Leclercq I , Pena AD , et al. Low-dose TNF-alpha protects against hepatic ischemia reperfusion injury in mice:implications for preconditioning[J]. Hepatology, 2003 ,37 (1):118-128.
14. Webber EM,Bruix J , Pierce RH , et al. Tumor necrosis factor primes hepatocytes for DNA replication in the rat [J ].Hepatology ,1998 ;28(5):1226-1234.
15. Yamada Y,Webber EM,Kirillova I,et al. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor :require2 ment for type 1 but not type 2 receptor [J] Hepatology ,1998 ;28 (4) :959-970.
16. Fausto N ,Riehle KJ.Mechanisms of liver regeneration and their clinical implications[J]. Hepatobiliary Pancreat Surg ,2005 ;12 (3) :181-189.
17. StreetzKL ,Luedde T, Manns MP, et al. Interleukin 6 and liver regeneration[J].Gut,2000; 47 (2) :309-312.
18. Iimuro Y,Nishiura T, Hellerbrand C, et al.NF-kappa B prevents apoptosis and liver dysfunction during liver regeneration[J ] . J Clin Invest ,1998 ;101 (4) :802-811.
19. Iimuro Y,Nishiura T ,Hellerbrand C , et al . NF-kappa B prevents apoptosis and liver dysfunction during liver regeneration[J ] . J Clin Invest ,1998 ;101 (4) :802-811.
20. Chen C , Edelstein LC , Gelinas C. The RelP NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl2x (L) [J ] . Mol Cell Biol ,2000 ;20 (8) :2687-2695.
21. Liu H ,Lo CR , Czaja MJ.NF-κB inhibition sensitizes hepatocytes to TNFa induced apoptosis through a sustained activation of JNK and c-Jun[J]. Hepatology, 2002; 35(4) :772-778.
22. Li W,Liang X,Kellendonk C , et al. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration [ J] . J Biol Chem,2002 ;277(32) :28411-28417.
23. Sakuda S ,Tamura S ,Yamada A , et al . Activation of signal transducer and activator transcription 3 and expression of suppressor of cytokine signal 1 during liver regeneration in rats[J ]. Hepatol ,2002 ;36 (3) : 378-384.
24. Koniaris LG,McKillop IH ,Schwartz SI , et al . Liver regeneration[J].Am Coll Surg , 2003;,197(4) :634-659.
25. Fausto N ,Riehle KJ .Mechanisms of liver regeneration and their clinical implications[J]. Hepatobiliary Pancreat Surg ,2005 ;12 (3) :181-189.
26. Chen Ping, Dong Xiaoling, Zhu Jin, et al. Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats[J]. Arch Med Res. 2006 ;37(5):576-83.
27. Ping C, Lin Z, Jiming D, Jin Z, et al.The phosphoinositide 3-kinase/Akt-signal pathway mediates proliferation and secretory function of hepatic sinusoidal endothelial cells in rats after partial hepatectomy[J]Biochem Biophys Res Commun. 2006 ;342(3):887-893.
28. Klein D, Demory A, Peyre F, et al . Wnt2 acts as a cell type-specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway [J]Hepatology. 2008;47(3):1018-1031.
29. Matsumoto K, Honda K, Kobayashi N. Protective effect of heat preconditioning of ratliver graft resulting in improved transplant survival[J].Transplantation. 2001;71(7): 862-868.
30. Arai M, Thurman RG, Lemasters JJ. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of nonparenchymal cells and the phenomenon of heterologous preconditioning Liver Transpl[J]. 2001;7(4):292-299.
31. Rentsch M, Post S, Palma P, et al.Anti-ICAM-1 blockade reduces postsinusoidal WBC adherence following cold ischemia and reperfusion, but does not improve early graft function in rat liver transplantation [J].Hepatol. 2000 ;32(5):821-8.
32. Ghobrial R, Amersi F, Stecker K,et al. Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides[J]. Transplant Proc. 2001;33(1-2):538-543.
33. Namisaki T, Yoshiji H, Kojima H, et al. Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats [J]. Hepatol. 2006;44(3):568-575.
34. Namisaki T, Yoshiji H, Kuriyama S, et al. A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats[J]. Hepatol Res. 2006;35(3):199-203.
1. Paavonen K, Horelli-Kuitunen N, Chilov D,et al. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively[J].Circulation. 1996;93(6):1079-1082.
2. Joukov V, Pajusola K, Kaipainen A,et al. A novel vascular endothelial growth factor,VEGF-C,is a ligand for the Flt4(VEGFR-3)and KDR(VEGFR-2)receptor tyrosine kinases[J]. EMBO J,1996;15(7):1751-1759.
3. Marc G,KuKK E. Vascular endothelial growth factor D(VEGF-D)is a ligand for the tyrosine kinases VEGF receptor 2(Flk1)and VEGF receptor 3(Flt40)[J]. PNAS,1998;95:548 -553.
4. Maglione D, Guerriero V, Viglietto G,et al. Isolation of a Human Placenta cDNA Coding for a Protein Related to the Vascular Permeability Factor[J]. Proc Natl Acad Sci U S A. 1991;88(20):9267-71.
5. Wise LM, Veikkola T, Mercer AA,. Vascular endothelial growth factor(VEGF)-like protein from virus NZ2 binds to VEGFR2 and neuropilin-1[J].Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3071-6 .
6. JohannesW, Lena CW, Agneta S, et al. Different signal transduc2tion p roperties of KDR and Flt - 1, two recep tors for vascular endo2thelial growth factor. J Biol Chem, 1994, 269 ( 43) : 26 988 -26 995.
7. Koch AE, Harlow LA, Haines GK, et al.Vascular endothelial growth factor- A cytokine modulating endothelial function in rheumatoid arthritis [J]. Immunol,1994; 152(8):4149-4156.
8. Meyer RD, Rahimi N. Comparative structure-function analysis of VEGFR-1 andVEGFR-2: What have we learned from chimeric systems[J], 2003;995:200-207.
9. Zhao J, Hu J, Cai J, et al. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma[J]. Chin Med J ( Engl) , 2003;116 (5) : 772 - 776.
10.陶厚权王瑞年.血管内皮生长因子与肿瘤[J].肿瘤,1997,17(1):52—54.
11. Marti HH, RisauW. Systemic hypoxia changes the organ– specific distribution of vascular endothelial growth factor and its receptors[J]. Proc Natl Acad Sci U S A. 1998;95(26):15809-15814.
12. Takahashi Y, Bucana CD, Cleary KR, et al.. p53, vessel count, and vascular endothelial growth factor expression in human colon cancer[J].Int J Cancer,1998;79(1):34-38.
13. VonMarschall Z, Scholz A, Cramer T, et al. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis[J]. J Natl Cancer Inst, 2003;95 (6) : 437 -448.
14. Malecki M, Trembacz H, Szaniawska B,et al.Vascular endothelial growth factor and soluble FLT-1 receptor interactions and biological implications[J].Oncol Rep. 2005;14(6):1565-1569.
15. Marchand GS, Noiseux N, Tanguay JF,et al. Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors[J]. Am J Physiol Heart Circ Physiol. 2002;282(1):194-204.
16. Masood R, Cai J, Zheng T,et al.Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A. 1997;94(3):979-84.
17. Rieder G, Hatz RA, Moran AP, et al. Role of adherence in interleukin - 8 induction in Helicobacter pylori - associated gastritis[J]. Infect Immun, 1997;65 (9) : 3622 -3630.
18. AsanoM, Yukita A, Suouki H. Wide spectrum of antitumor activity of a neutralizingmonoclonal antibody to human vascular endothclial growth factor[ J ]. Jpn J Cancer Res, 1999;90 (1) : 93-100.
19. Hc Y, Smith SK, Day KA, et al. Alternative sp licing of vascular endothelial growth factor (VEGF) - R1 ( FLT-1) pre–mRNA is important for the regulation ofVEGF activity[J]. Mol Endocrinol,1999, 13 (4) : 537 - 545.
20. Perez-Ruiz M ,Ros J,Morales-Ruiz M,et al.Vascular endothelial growth factorproduction in pe ritoneal macorophages of cirrhotic pa tients regulation by cytokines and bacterial lipopoly sacharide [J] .Hepatolog) ,1999;29(4):1057-l063.
21. Rosmorduo 0,Wendum D,Corpechot C,et a1.Hpatecellular Hypoxia induced vascular endothelial growth factor expression and an glogenesis in experimental biliary cirrhosis[J].Am J Pathol,1999;155(4):1065-1073.
22. Kraft A,Weindel K,Ochs A, et a1.Vascular endothelial growth factor in the sera and effusions of patients with malignant and non-malignant disease. [J].Cancer,1999; 85(1);178-187.
23. Desider G,Ferri C.Circulating vascular endothelial growth factor levels are dec- reased in patients with chronic hepatitis and liver cirrhosis depending on the degree of hepatic demge[J].Clin Sci(colch);2000;99(2):159-160.
24. Assy N, PaiziM, GaitiniD, et al. Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension[J]. World J Gastroenterol, 1999;5 (4) : 296 - 300.
25. Akiyoshi F, SaraM, Suzuki H, et al. Serum vascular endothelial growth factor levels in various liver diseases[J]. Dig Dis Sci, 1998;43 (1) : 41 - 45.
26. El-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver[J].Hepatology.1998;27(6):1554-62.
27. Raleigh JA, Calkins - Adams DP, Rinker LH, et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinoma using p imonidazole as a hypoxia marker[J].Cancer Res,1998;58 (17) :3765 -3768.
28. Yoshiji H, Kuriyama S, Yoshii, et al. Vascular endothelial growth factor and recep tor interaction is a p rerequisite formurine hepatic fibrogenesis[J]. Gut, 2003;52(9) :1347 - 1354.
29. Niimi Y,Mochida S, MatsuiA, et al. PKC– and MAPK - independent upregulation of VEGF receptor expressions in human umbilical venous endothelial cells following VEGF stimulation[J]. HepaZol Res, 2001;21(3):261-267.
30. Hiscock N,Fischer C P,Pilegaard H,et al. Vascular endothelial growth factor mRNA expression and arteriovenous balance in response to prolonged,submaximal exercise inhumans[J]. Am J Physiol Heart Circ Physiol,2003;285;1759-1763.
31. Hiroaki Shimizu,Masaru Miyazaki. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats[J]. Journal of Hepatology,2001;34:683 - 689.
32. Mochida S, Ishikawa K, Inao M, et a1. Increased exp ressions of vascular endothe lial growth factor and its recop tors, f1 t -1 and KDR / flk - 1, in regenerating rat liver[J]. Biochem B iophys Res Commun, 1996;226 (1) : 176-179.
33. Kraizer Y,Mawasi N, Seagal J, et a1. Vascular endothelial growth factor and angiop oietin in liver regeneration[J]. Biochem Biophys Res Commun, 200 l;287 (1):209 - 215.
34. Assy N, Spira G, Paizi M, et a1. Effect of Vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats[J]. Hepato1, 1999;30 (5) : 911- 9 l5.
35. Taniguchi E, Sakisaka S,Matsuo K, et a1. Expression and role of vascu1ar endothelial growth factor in liver regeneration after partia1 hepatectomy in rats[J]. J Histochem Cytochem,2001,49 (1 ):121 - l30.
36. Ronco MT, Francés D, de Luján Alvarez M,et al. Vascular endothelial growth factor and nitric oxide in rat liver regeneration[J]. Life Sci. 2007;81(9):750-755.
37. Bockhorn M, Goralski M, Prokofiev D,et al. VEGF is important for early liver regeneration after partial hepatectomy[J] Surg Res. 2007 Apr;138(2):291-299.
38. Sato T, El - Assal ON,Ono T, et a1. Sinusoida1 endothe1 ial ce1l pro1iferation and exp ression of angiopoietin /Tie fami1y in regenerating rat liver[J]. Hepatol, 2001; 34 (5): 690 - 698.
39. SengerD R, Galli SJ,Dvorak AM, et a1. Tumor cel1s secrete vascular permeability factor that promotes accumu1ation of ascites fluid[J]. Science, 1983, 219 (4587) : 983 - 985.
40. Akiyoshi F, Sara M, Suzuki H, et al.Serum vascular endothelial growth factor levels in various liver disease[J].Dig Dis Sei,1998;43(1):41.
41. Janczewska-Kazek E, Marek B, Pisula A,et al.Serum levels of vascular endothelial growth factor in chronic hepatitis C patients treated with interferon alpha and ribavirin[J]. Wiad Lek. 2007;60(3-4):120-123.
42. Marino G, Piazzese E, Gruttadauria S, et al. New model of liver regeneration induced through use of vascular endothelial growth factor[J].Transplant Proc,2006;38(4): 1193-1194.
43. Marino G, Piazzese E, Gruttadauria S,et al. Innovative use of the vascular endothelial growth factor in an experimental model of acute liver failure[J]. ,2004;25(3):61-64.
44. Donahower B, McCullough SS, Kurten R,et al. Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity[J].Am J Physiol Gastrointest Liver Physiol, 2006 ;291(1):G102-109.
45. Namisaki T, Yoshiji H, Kojima H,et al. Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats[J].J Hepatol. 2006 ;44(3):568-75.
46. Kusumanto YH, van Weel V, Mulder NH,et al. A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats[J]. Hepatol Res, 2006;35(3):199-203.
47. Ajioka I,Nishio R, Ikekita M, et a1. Establishment of heterotropic liver tissue mass with direct link to the host liver following implantation of hepatocytes transfected with vascular endothelial growth factor gene in mice[J]. Tissue Eng, 2001, 7 (3) : 335 - 344.
48. Yang ZF, Poon RT, Luo Y, et al. Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway[J]. J Immunol. 2004 ,15;173(4):2507-2515.
1. Fausto N, Webber EM. Control of liver growth[J]. Crit Rev Eukaryot Gene Expr 1993;3:117–135.
2. Fausto N. Liver regeneration[J]. J Hepatol 2000;32(Suppl 1):19–31.
3. Higgins GM, Anderson RM. Restoration of liver following partial surgical removal[J]. Arch Pathol 1931;12:186–202.
4. Giuliano R, Ramadori G, Armbrust T. Cytokines in the liver[J]. Eur J Gastroenterol Hepatol 2001;13:777–784.
5. Koniaris LG, McKillop IH, Schwartz SI, Zimmers TA. Liver regeneration[J].J Am Coll Surg 2003;197:634–659.
6. Daveau M, Scotte M, Francois A, et al.Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma[J].Mol Carcinogen 2003;36:130–141.
7. Suzuki A, Iwama A, Miyashita H, Nakauchi H, Taniguchi H. Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells[J]. Development 2003;130:2513–2524.
8. Peters M, Blinn G, Jostock T, et al. Buschenfelde KH, et al. Combined interleukin 6 and soluble interleukin-6 receptor accelerates murine liver regeneration[J]. Gastroenterology 2000;119:1663–1671.
9. Debonera F, Aldeguer X, Shen X, et al. Activation of interleukin-6/STAT3 and liver regeneration following transplantation[J]. J Surg Res 2001;96:289–295.
10. Tanaka H, Hashizume K, Enosawa S, Suzuki S. Successful transplantation of a 20% partial liver graft in rats: a technical innovation. J Surg Res 2003; 110: 409.
11. Guo L, Haga S, Enosawa S, et al. Improved Hepatic regeneration with reduced post-ischemic injury by redoxfactor-1 gene transfer in a rat small size-liver transplant model[J]. Am J Transplant 2004; 4: 879-887.
12. Chen Ping, Dong Xiaoling, Zhu Jin, et al. Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats[J]. Arch Med Res. 2006 ;37(5):576-583
13. Namisaki T, Yoshiji H, Kojima H, et al .Salvage effect of the vascular endothelialgrowth factor on chemically induced acute severe liver injury in rats[J]. Hepatol.,2006, 44(3):568-576.
14. Donahower B, McCullough SS, Kurten R, et al Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity[J]. Am J Physiol Gastrointest Liver Physiol. 2006 ; 291(1):G102-9.
15. Marino G, Piazzese E, Gruttadauria S, et al. New model of liver regeneration induced through use of vascular endothelial growth factor[J].Transplant Proc. 2006 ;38(4):1193-1194.
16. Namisaki T, Yoshiji H, Kojima H, et al .Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats[J]. Hepatol,2006, 44(3):568-576.
17. Marino G, Piazzese E, Gruttadauria S.et al. New model of liver regeneration induced through use of vascular endothelial growth factor[J]. Transplant Proc,2006 ; 38(4): 1193-1194.
18. Ijichi H, Taketomi A, Yoshizumi T, et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy.[J ] Hepatol, 2006,45(1):28-36.
19. Donahower B, McCullough SS, Kurten R, et al.Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity. Am J Physiol Gastrointest[J] Liver Physiol. 2006 ,291(1):102-109
20. Marino G, Piazzese E, Gruttadauria S.et al. New model of liver regeneration induced through use of vascular endothelial growth factor[J]. Transplant Proc,2006 ; 38(4):1193-1194.
21. Chen Ping, Dong Xiaoling, Zhu Jin, et al. Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats[J]. Arch Med Res. 2006 ,37(5):576-583.
22. Malik R, Selden C, Hodgson H. The role of non-parenchymal cells in liver growth[J]. Semin Cell Dev Biol 2002;13:425–431.
23. Higgins GM, Anderson RM. Restoration of liver following partial surgical removal[J]. Arch Pathol 1931;12:186–202.